FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+16.03%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$34.4B
AUM Growth
+$4.09B
(+13%)
Cap. Flow
+$435M
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
33.66%
Holding
538
New
44
Increased
179
Reduced
177
Closed
80
Top Buys
| 1 |
Qualcomm
QCOM
|
$338M |
| 2 |
Advanced Micro Devices
AMD
|
$141M |
| 3 |
Natera
NTRA
|
$141M |
| 4 |
TSMC
TSM
|
$125M |
| 5 |
iRhythm Technologies
IRTC
|
$120M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$198M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$136M |
| 3 |
Danaher
DHR
|
$114M |
| 4 |
CrowdStrike
CRWD
|
$113M |
| 5 |
EPAM Systems
EPAM
|
$113M |
Sector Composition
| 1 | Technology | 34.35% |
| 2 | Healthcare | 20.3% |
| 3 | Consumer Discretionary | 16.37% |
| 4 | Communication Services | 9.55% |
| 5 | Financials | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Boeing
BA
$174B
| $6K | ﹤0.01% |
35
| – | – |
|
452
Exxon Mobil
XOM
$479B
| $6K | ﹤0.01% |
165
-29,684
| -99% | -$1.08M |
|
453
Biogen
BIIB
$20.5B
| $5K | ﹤0.01% |
17
-3,850
| -100% | -$1.13M |
|
454
L3Harris
LHX
$51.1B
| $3K | ﹤0.01% |
19
| – | – |
|
455
Charles Schwab
SCHW
$177B
| $3K | ﹤0.01% |
71
| – | – |
|
456
Goldman Sachs
GS
$227B
| $2K | ﹤0.01% |
8
| – | – |
|
457
Carrier Global
CARR
$54.1B
| $1K | ﹤0.01% |
25
| – | – |
|
458
Otis Worldwide
OTIS
$33.9B
| $1K | ﹤0.01% |
13
| – | – |
|
459
Afya
AFYA
$1.35B
| – | – |
-26,253
| Closed | -$615K |
|
460
Akebia Therapeutics
AKBA
$801M
| – | – |
-90,000
| Closed | -$1.22M |
|
461
Air Lease Corp
AL
$7.11B
| – | – |
-316
| Closed | -$9K |
|
462
Allogene Therapeutics
ALLO
$246M
| – | – |
-13,000
| Closed | -$557K |
|
463
Alnylam Pharmaceuticals
ALNY
$59.4B
| – | – |
-18,558
| Closed | -$2.75M |
|
|
AMRN
464
Amarin Corp
AMRN
$311M
| – | – |
-3,600
| Closed | -$498K |
|
465
Aon
AON
$80.5B
| – | – |
-151
| Closed | -$29K |
|
466
Ascendis Pharma
ASND
$12B
| – | – |
-5,000
| Closed | -$740K |
|
467
Becton Dickinson
BDX
$54.8B
| – | – |
-68
| Closed | -$16K |
|
468
Bio-Rad Laboratories Class A
BIO
$7.83B
| – | – |
-11,612
| Closed | -$5.24M |
|
|
BLUE
469
DELISTED
bluebird bio
BLUE
| – | – |
-386
| Closed | -$305K |
|
470
Brookfield
BN
$99.6B
| – | – |
-100,649
| Closed | -$2.66M |
|
471
CBRE Group
CBRE
$48.1B
| – | – |
-500
| Closed | -$23K |
|
472
Crown Holdings
CCK
$10.7B
| – | – |
-207
| Closed | -$13K |
|
473
CDW
CDW
$21.8B
| – | – |
-106
| Closed | -$12K |
|
474
Choice Hotels
CHH
$5.42B
| – | – |
-145
| Closed | -$11K |
|
475
Centene
CNC
$14.1B
| – | – |
-31,908
| Closed | -$2.03M |
|